Cargando…

Hypo-glycosylated follistatin-like 1 for new cardiomyocyte formation

Detalles Bibliográficos
Autor principal:	Kerkelä, Risto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114625/ https://www.ncbi.nlm.nih.gov/pubmed/35615706 http://dx.doi.org/10.1016/j.omtm.2022.04.005

Ejemplares similares

Follistatin-Like 1 Attenuates Ischemia/Reperfusion Injury in Cardiomyocytes via Regulation of Autophagy
por: Yang, Weijun, et al.
Publicado: (2019)

A role for Follistatin-like protein 1 (FSTL1) in colorectal cancer
por: Voutsadakis, Ioannis A.
Publicado: (2020)

Follistatin-Like 1: Growing Evidence for Its Beneficial Role in Heart Failure
por: Wollert, Kai C.
Publicado: (2016)

Fellows’ Hypo Phosphites
Publicado: (1880)

Follistatin-like 1 promotes proliferation of matured human hypoxic iPSC-cardiomyocytes and is secreted by cardiac fibroblasts
por: Peters, Marijn C., et al.
Publicado: (2022)

Follistatin-like 1 in development and human diseases
por: Mattiotti, Andrea, et al.
Publicado: (2018)

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?
por: Kaplan, Huseyin, et al.
Publicado: (2023)

Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity
por: Fan, Nengguang, et al.
Publicado: (2013)

Follistatin like-1 (Fstl1) is required for the normal formation of lung airway and vascular smooth muscle at birth
por: Liu, Xue, et al.
Publicado: (2017)

Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?
por: Parola, Maurizio
Publicado: (2022)

Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
por: Alakoski, Tarja, et al.
Publicado: (2019)

Follistatin-Like Proteins: Structure, Functions and Biomedical Importance
por: Parfenova, Olga K., et al.
Publicado: (2021)

The BMP Antagonist Follistatin-Like 1 Is Required for Skeletal and Lung Organogenesis
por: Sylva, Marc, et al.
Publicado: (2011)

Follistatin like-1 aggravates silica-induced mouse lung injury
por: Fang, Yinshan, et al.
Publicado: (2017)

Clinical implications of circulating follistatin-like protein-1 in hemodialysis patients
por: Kim, Dae Kyu, et al.
Publicado: (2023)

Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer
por: Liu, Zhen, et al.
Publicado: (2023)

Role of follistatin-like 1 levels and functions in calcific aortic stenosis
por: Zhang, Qianru, et al.
Publicado: (2023)

The BMP inhibitor follistatin-like 1 (FSTL1) suppresses cervical carcinogenesis
por: Zhao, Chenjing, et al.
Publicado: (2023)

Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells
por: Shi, Feng-Tao, et al.
Publicado: (2011)

A patient-based medaka alg2 mutant as a model for hypo-N-glycosylation
por: Gücüm, Sevinç, et al.
Publicado: (2021)

Novel Screening Method Identifies PI3Kα, mTOR, and IGF1R as Key Kinases Regulating Cardiomyocyte Survival
por: Elmadani, Manar, et al.
Publicado: (2019)

Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice
por: Dong, Yingying, et al.
Publicado: (2015)

Follistatin-Like 1 Regulates Hypertrophy in Heart Failure With Preserved Ejection Fraction
por: Tanaka, Komei, et al.
Publicado: (2016)

Follistatin-like protein 1 sustains colon cancer cell growth and survival
por: Bevivino, Gerolamo, et al.
Publicado: (2018)

Follistatin-Like 1 Is Downregulated in Morbidly and Super Obese Central-European Population
por: Horak, Martin, et al.
Publicado: (2018)

Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice
por: Zhang, Wei, et al.
Publicado: (2017)

The Follistatin‐like Protein 1 Pathway Is Important for Maintaining Healthy Articular Cartilage
por: Chaly, Yury, et al.
Publicado: (2020)

Thrombin generation: a global coagulation procedure to investigate hypo- and hyper-coagulability
por: Tripodi, Armando
Publicado: (2020)

Hypo and Hyperthyroidism
por: Hixson, J. S.
Publicado: (1915)

The Expression of Follistatin-like 1 Protein Is Associated with the Activation of the EMT Program in Sjögren’s Syndrome
por: Sisto, Margherita, et al.
Publicado: (2022)

Follistatin‐like 1 promotes cardiac fibroblast activation and protects the heart from rupture
por: Maruyama, Sonomi, et al.
Publicado: (2016)

Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma
por: Zhou, Xiaoying, et al.
Publicado: (2016)

Prognostic value of follistatin-like 3 in human invasive breast cancer
por: Couto, Henrique L., et al.
Publicado: (2017)

Follistatin like protein (FSTL-1) levels are elevated in acute Kawasaki Disease and may differentiate between patients with and without aneurysm formation
por: Gorelik, Mark, et al.
Publicado: (2012)

Follistatin and the Breast Implant Capsule
por: Frenkiel, Brett A., et al.
Publicado: (2017)

Special Issue: New Insights into Protein Glycosylation
por: Kurebayashi, Yuuki, et al.
Publicado: (2023)

Association of Circulating Follistatin-Like 1 Levels with Inflammatory and Oxidative Stress Markers in Healthy Men
por: Hayakawa, Satoko, et al.
Publicado: (2016)

Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2
por: Zhao, Yintao, et al.
Publicado: (2020)

Endothelial extracellular vesicles induce acute lung injury via follistatin-like protein 1
por: Yuan, Hao-Xiang, et al.
Publicado: (2023)

Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers
por: Tian, Shifeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2iqd4a5eh9r9ntckc161l2tskh